CerebrAlcare Pills on CereBral Small VesseL DiseasE(CABLE)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 114 participants.
Also called NCT05578521
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 114 participants
- Registry
-
NCT05578521
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT05578521. Randomized; quadruple masking; primary purpose treatment. Start 2022-06-05 (actual); primary completion 2023-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- CerebrAlcare Pills on CereBral Small VesseL DiseasE(CABLE)
- Condition
- Cerebral Small Vessel Diseases
- Intervention (Drug)
- Cerebralcare pills
- Intervention (Drug)
- Cerebralcare pills placebo
- Lead sponsor
- Beijing Tiantan Hospital
- Collaborator
- Tasly Pharmaceutical Group Co., Ltd
Record details
- Record id
cardio:ct-nct05578521- Content hash
139b280e27176bf06d2c4b75cbd1206845c829f4621ec47227d9537ea1e1a7ed